WUXI BIOLGCS ADR News

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$23.25 From HK$53.65, Keeps at Buy

MT NewswiresJul 24 05:33 ET

Bank of China Downgrades Wuxi Biologics (Cayman) to Hold From Buy, Price Target Is HK$14

MT NewswiresJun 27 03:32 ET

Nomura Adjusts Wuxi Biologics' Price Target to HK$53.65 From HK$58.44, Keeps at Buy

MT NewswiresMar 1 04:05 ET

Nomura Adjusts Wuxi Biologics' Price Target to HK$58.44 From HK$82.69, Keeps at Buy

MT NewswiresDec 5, 2023 06:14 ET

Nomura Adjusts Wuxi Biologics' Price Target to HK$82.69 From HK$86.68, Keeps at Buy

MT NewswiresJul 24, 2023 06:46 ET

Nomura Adjusts WuXi Biologics (Cayman)'s Price Target to HK$86.86 From HK$94.91, Keeps at Buy

MT NewswiresJun 21, 2023 05:40 ET

Wuxi Biologics Target Price Cut to HK$84.90 From HK$94.00 by Daiwa Capital>2269.hk

Dow JonesMar 23, 2023 23:27 ET

Nomura Adjusts WuXi Biologics' Price Target to HK$94.91 From HK$97.78, Keeps at Buy

MT NewswiresFeb 14, 2023 05:04 ET

UBS Adjusts Wuxi Biologics’ Price Target to HK$113.12 From HK$110.67, Keeps at Buy

MT NewswiresAug 22, 2022 05:23 ET

Nomura Adjusts WuXi Biologics' Price Target to HK$97.78 From HK$95.75, Keeps at Buy

MT NewswiresAug 5, 2022 05:30 ET

UBS Adjusts Wuxi Biologics (Cayman)'s Price Target to HK$95.75 From HK$100.87, Keeps at Buy

MT NewswiresJun 8, 2022 23:42 ET